Ingredient Literacy
What Is PEA? Palmitoylethanolamide, Explained Simply
Three letters on a Supplement Facts panel can look like leftover lab notation. PEA sits there, often next to turmeric or all by itself, and careful shoppers skip it because the name does not sound like food. Palmitoylethanolamide is a fatty amide the body already makes. Researchers first isolated it from soy lecithin, egg yolk, and peanut flour. The useful fact is not the acronym. It is that a lipid used in the body’s own comfort and balance pathways now appears on a label with a milligram amount next to it.
Key Takeaways
- PEA stands for palmitoylethanolamide, an N-acylethanolamine the body produces on its own.
- It was first isolated from ordinary foods (soy lecithin, egg yolk, peanut flour), not invented for a product page.
- Published pharmacology points mainly to PPAR-alpha, a nuclear receptor involved in lipid metabolism and inflammatory signaling, rather than classic cannabinoid receptors. For the deeper mechanism story, see how PEA supports other signaling fats through the entourage effect.
- Extra-Strength PEA Capsules are formulated for nerve comfort and inflammatory balance. PEA Gummies are formulated for joint comfort. For the nighttime side of everyday nerve comfort, see Nerve Comfort Explained: Why Hands Fall Asleep at Night.
- Named milligrams beat a mystery blend. The capsules list 550 mg of PEA. The gummies list 300 mg, plus boswellia and bromelain.
A bottle that does not hide the milligrams
People who already ignore claims still want one ordinary thing: to know what is in the bottle. PEA as a single line item, with a number, is the opposite of a proprietary fog. Extra-Strength PEA Capsules put palmitoylethanolamide on the panel at 550 mg, vegan, gluten-free, with a certificate of analysis for the batch. That is the whole pitch. A fatty amide the body already makes, dosed in the open.
The formulators were not hunting a new slogan for joint comfort. They were solving a trust problem. If a lipid shows up in the literature under a long chemical name, the label should use that name and the milligrams, not a blend that buries both.
PEA, in one sentence. Palmitoylethanolamide (N-hexadecanoylethanolamide) is an endogenous fatty acid amide in the N-acylethanolamine family. The body synthesizes it. Enzymes involved in its metabolism, including NAAA and FAAH, help degrade it. It is not a vitamin with a recommended daily intake, and it is not a cannabinoid in the CB1/CB2 sense.
How PEA talks to cells
Say palmitoylethanolamide out loud once (pal-mit-oh-il-eth-an-ol-amide) and the mystery shrinks. Palmitic acid is a common 16-carbon fat. Ethanolamide is the head group. Stick them together and the cell has a lipid messenger, not a mineral and not a botanical extract.
For decades after the 1950s isolation, the receptor story lagged. In 2005, Lo Verme and colleagues identified the ligand-activated transcription factor PPAR-alpha as a key receptor for PEA’s effects on inflammatory signaling. A 2020 pharmacology review by Rankin and Fowler reached the same center of gravity: most of PEA’s biological effects appear secondary to PPAR-alpha, with additional PPAR-alpha-independent routes that can involve TRPV1 and GPR55.
PPAR-alpha is not a slogan. It is a nuclear receptor already known for lipid metabolism and for damping certain inflammatory transcription programs. That is mechanism, not a promise that a capsule will do what a paper did in mice. Ingredient research is not product evidence. The honest sentence is narrower: PEA is a studied fatty amide that acts, in large part, through a receptor the body already uses to keep inflammatory signaling in range.
Reviews of the compound’s history also note that PEA has been known since the 1950s as a nutritional factor isolated from plant and animal foods. The amounts in egg yolk or peanuts are not a substitute for a labeled serving. Food is still food. The capsule exists because the milligram amount on a panel is something a person can actually compare.
Sources: Lo Verme et al., Life Sciences, 2005; Rankin and Fowler, International Journal of Molecular Sciences, 2020; Della Rocca and Re, Veterinary Sciences, 2020.
What PEA is, and what it is not
| PEA is | PEA is not |
|---|---|
| A fatty amide the body already makes | A vitamin with a standard daily value |
| First isolated from soy lecithin, egg yolk, and peanut flour | A replacement for dinner, or a reason to skip food |
| Studied mainly as a PPAR-alpha agonist | A classic cannabinoid acting at CB1 or CB2 |
| A line item that can be printed in milligrams | A proprietary blend that hides the dose behind a total |
When the format is a gummy
Not every routine wants a capsule. PEA Gummies keep palmitoylethanolamide on the panel at 300 mg and pair it with boswellia serrata extract (50 mg) and bromelain (50 mg). The job of that formula is joint comfort and everyday mobility, not a new chemical story. Same lipid. Chewable format. Two botanicals that are themselves studied for a healthy inflammatory response.
The gummy is still a supplement facts problem, not a flavor problem. If the milligrams are printed, the chewable earns a place next to the capsule. If they are not, it is candy with a lecture attached.
The Bottom Line
PEA is palmitoylethanolamide, a lipid messenger the body already synthesizes, first pulled out of ordinary foods in the 1950s and later tied, in the papers, to PPAR-alpha. It is not a mystery mineral and it is not a cannabinoid by another name. On a Well Theory panel it is a number: 550 mg in the Extra-Strength capsules, 300 mg in the gummies. Read the letters. Then read the milligrams. That is the whole lesson.
Frequently Asked Questions
What does PEA stand for in a supplement?
PEA stands for palmitoylethanolamide, also written N-hexadecanoylethanolamide. It is an endogenous fatty acid amide in the N-acylethanolamine family, not a protein and not a plant extract.
Is PEA a cannabinoid?
No. PEA is often grouped with endocannabinoid-like lipids because it is an N-acylethanolamine, the same chemical family as anandamide. Reviews place most of its effects at PPAR-alpha, not at the classic CB1 and CB2 cannabinoid receptors.
Can food supply PEA?
PEA was first isolated from soy lecithin, egg yolk, and peanut flour, and it occurs in other plant and animal foods. Those amounts are not a labeled serving. Food remains the base. A supplement is a milligram amount a person can compare on a panel.
What are PEA supplements formulated to support?
Structure and function, not a diagnosis. Extra-Strength PEA Capsules are formulated for nerve comfort and inflammatory balance. PEA Gummies are formulated for joint comfort and everyday mobility. Neither is a substitute for medical care.
Why do some PEA products use a gummy and some a capsule?
Format is a habit question. The capsules are a single-ingredient 550 mg PEA serving. The gummies use 300 mg PEA plus boswellia serrata extract and bromelain. Both print the milligrams. That is the comparison that matters.
Has PEA been studied in humans?
Yes. Pharmacology reviews describe PEA as well tolerated and summarize a large experimental literature. That is not the same as proving any one finished bottle. Form, dose, and formula have to match before a study becomes product evidence. Prefer “has been studied” over “clinically proven.”
